Can you stack BPC-157 with ipamorelin?

Why This Stack Is Common

Ipamorelin is a growth hormone secretagogue that stimulates the pituitary to release pulses of endogenous growth hormone. Paired with CJC-1295 (a GHRH analog), it produces a clean, selective GH pulse that supports:

• Recovery from training
• Lean mass preservation and gradual gain
• Sleep quality (GH pulses normally peak during deep sleep)
• Fat metabolism
• Skin and tissue quality

BPC-157 adds direct tissue-level repair signaling. The combination is popular in athletes and active adults who want accelerated recovery + systemic regenerative support.

Typical Protocol

• BPC-157: 250–500 mcg subcutaneously once or twice daily
• CJC-1295 + Ipamorelin: 100–300 mcg each, subcutaneously at bedtime, 5 nights per week
• Cycle length: 8–12 weeks, with 4-week break before repeating

Why Bedtime Dosing for Ipamorelin

GH pulses naturally rise during slow-wave sleep. Dosing ipamorelin at bedtime aligns the pharmacologic pulse with physiologic timing. This usually also improves sleep quality through mechanisms that aren't fully understood but are consistently reported.

Separation From BPC-157 Dosing

BPC-157 dosing doesn't need to align with ipamorelin timing. Many patients take:

• BPC-157 morning and afternoon
• CJC-1295 + ipamorelin before bed

Same general rule: separate syringes, separate injection sites, not mixed.

Expected Combined Effects

• Injury-specific improvement from BPC-157 (tendonitis, gut, muscle)
• Broader recovery quality from ipamorelin/CJC-1295 — less post-workout fatigue, better sleep
• Possible improvements in body composition over 8–12 weeks (fat reduction, slight lean mass gain)
• Better skin hydration and sleep quality

Safety Considerations

• Water retention: some users experience mild water retention with ipamorelin/CJC-1295, particularly in the first 2 weeks
• Tingling or numbness: occasional with GH secretagogues, typically transient
• Hunger and blood sugar: GH pulses can increase appetite and mildly raise blood sugar — monitor if diabetic
• Site-specific injection reactions: standard; rotate sites
• Cancer history: GH secretagogues are generally contraindicated in active or recent cancer; discuss with oncology

When This Stack Makes Sense

• Athletes and active adults with specific injury + general recovery goals
• Post-surgical patients wanting both focal and systemic support
• Adults over 40 with chronic low-grade recovery issues

When to Skip Ipamorelin and Just Run BPC-157

• Gut-only focus (ipamorelin adds no gut benefit)
• Budget constraints (the stack roughly doubles monthly cost)
• Active malignancy or recent cancer
• Poorly controlled diabetes or significant metabolic dysfunction

See BPC-157, ipamorelin, and CJC-1295 guides. Related: Wolverine Stack dosage.